Search research articles
Contact Us
Filters
Showing results (231-240 of 245) with videos related to
Page
of 25
Sort By:
Nature Medicine
|
September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2020
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma
Lauren E Haydu, Serigne N Lo, Jennifer L McQuade, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2021
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
R V Rawson, C Adhikari, C Bierman, et al.
Cancer Discovery
|
September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Felicity Newell, Peter A Johansson, James S Wilmott, et al.
JAMA Dermatology
|
April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
Serigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Nature Communications
|
July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newell, Yan Kong, James S Wilmott, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 245) with videos related to
Sort By:
Page
of 25
Nature Medicine
|
September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2020
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma
Lauren E Haydu, Serigne N Lo, Jennifer L McQuade, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2021
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
R V Rawson, C Adhikari, C Bierman, et al.
Cancer Discovery
|
September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Felicity Newell, Peter A Johansson, James S Wilmott, et al.
JAMA Dermatology
|
April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
Serigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Nature Communications
|
July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newell, Yan Kong, James S Wilmott, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Page
of 25